Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going

Abstract

Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over the last decade since the first trials including inoperable or very high risk patients. Thus, TAVR is now the most common treatment of aortic valve stenosis in elderly patients (vs. surgical aortic valve replacement-SAVR-). In this review, we summarize the current indications of TAVR and explore future directions in which TAVR indications can expand.